|
WO9808090A1
|
|
Anti-idiotypic antibodies to an epiglycanin
|
|
AU6775096A
|
|
Anti-idiotypic antibodies to an epiglycanin
|
|
US5736394A
|
|
Cellular uptake of modified peptides
|
|
US5830478A
|
|
Method for delivering functional domains of diphtheria toxin to a cellular target
|
|
WO9112023A2
|
|
Hybrid reagents capable of selectively releasing molecules into cells
|
|
US5292668A
|
|
Bispecific antibody determinants
|
|
US5064941A
|
|
Collagen extracted from collagen-containing tissue
|
|
EP0328372A2
|
|
Method for determining antigen
|
|
US4983721A
|
|
Solvents for collagen
|
|
US4710462A
|
|
Cell proliferation inhibitor and method of preparation
|
|
US4770877A
|
|
Isolation of a high molecular weight aortic endothelial cell growth inhibitor
|
|
AU4290185A
|
|
Bispecific antibody determinants
|
|
US4474742A
|
|
Treatment of asbestos
|
|
IT8367057D0
|
|
Homogeneous identical bi:specific antibody determinants
|
|
US4534967A
|
|
Cell proliferation inhibitor and method of preparation
|
|
US4444878A
|
|
Bispecific antibody determinants
|
